17-5033015-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000254853.10(SLC52A1):āc.1289C>Gā(p.Thr430Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000254853.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC52A1 | NM_017986.4 | c.1289C>G | p.Thr430Ser | missense_variant | 5/5 | ENST00000254853.10 | NP_060456.3 | |
LOC105371501 | XR_002958101.2 | n.339+1346G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC52A1 | ENST00000254853.10 | c.1289C>G | p.Thr430Ser | missense_variant | 5/5 | 1 | NM_017986.4 | ENSP00000254853 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250242Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135252
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461526Hom.: 0 Cov.: 30 AF XY: 0.0000344 AC XY: 25AN XY: 727040
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74472
ClinVar
Submissions by phenotype
Ariboflavinosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2021 | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with SLC52A1-related conditions. This variant is present in population databases (rs568958678, gnomAD 0.05%). This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 430 of the SLC52A1 protein (p.Thr430Ser). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at